Clinical Trial Update: Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 open-label, randomized, three-arm parallel-group single-dose pharmacokinetic study in healthy subjects. It assesses safety and immunogenicity of an inve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Kashiv BioSciences, LLC | Conditions: Rheumatoid Arthritis (RA | Phase 1 | Status: COMPLETED